Increased Peripheral Proinflammatory T Helper Subsets Contribute to Cardiovascular Complications in Diabetic Patients

Table 1

Demographic characteristics of subjects.

	Non-CHD	CHD	𝑃
𝑁	42	67
Age (year)	56.79 ± 14.978	61.48 ± 12.73	0.096
Sex (M/F)	19/23	39/28	0.190
Duration (year)	10.10 ± 8.09	11.44 ± 7.50	0.387
BMI (kg/m^2)	25.00 ± 4.73	25.94 ± 4.72	0.314
Lymphocyte (10^9/L)	1.76 ± 0.48	2.03 ± 0.89	0.041*
TG (mmol/L)	2.02 ± 1.91	2.05 ± 1.43	0.937
LDL-L (mmol/L)	2.59 ± 0.71	3.35 ± 0.92	0.000**
HDL-L (mmol/L)	1.22 ± 0.28	1.14 ± 0.24	0.134
T-Cho (mmol/L)	4.69 ± 1.01	5.24 ± 1.16	0.010*
CD4+ (%)	37.83 ± 8.30	38.42 ± 10.28	0.743
CRP (mg/L)	2.27 ± 2.34	5.61 ± 4.21	0.000**
ln (HOMA-IR)	0.66 ± 0.81	1.39 ± 0.64	0.000**

BMI: body mass index; non-CHD: patients with type 2 diabettes but without CHD; CHD: patients with type 2 diabetes and CHD; CRP: C-reactive protein; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; T-Cho: total cholesterol; TG: total triglycerides.
*Statistically significant at level of 𝑃<0.05.
**Statistically significant at level of 𝑃<0.01.